
Sign up to save your podcasts
Or


In this enlightening episode, Dr. Kevin Korenblat from Washington University in St. Louis explores the intricacies of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).
Click here to access his list of active clinical trials: http://resfyh.com/SP0121
Click here to sign up for his monthly SMS-based study updates: http://resfyh.com/SI0121
Gain valuable insights into the latest research, effective treatment options, and practical prevention strategies. Dr. Korenblat also highlights the benefits of participating in clinical trials, offering listeners a chance to learn how these trials can provide access to cutting-edge treatments and contribute to groundbreaking medical advancements. Tune in to stay informed and take control of your liver health.
By Researchify HealthIn this enlightening episode, Dr. Kevin Korenblat from Washington University in St. Louis explores the intricacies of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).
Click here to access his list of active clinical trials: http://resfyh.com/SP0121
Click here to sign up for his monthly SMS-based study updates: http://resfyh.com/SI0121
Gain valuable insights into the latest research, effective treatment options, and practical prevention strategies. Dr. Korenblat also highlights the benefits of participating in clinical trials, offering listeners a chance to learn how these trials can provide access to cutting-edge treatments and contribute to groundbreaking medical advancements. Tune in to stay informed and take control of your liver health.